InvestorsHub Logo
Followers 38
Posts 1440
Boards Moderated 0
Alias Born 03/07/2004

Re: honestabe13 post# 39920

Friday, 08/07/2009 3:30:01 PM

Friday, August 07, 2009 3:30:01 PM

Post# of 346050
honestabe:you are that:honest. I have given this subject some minutes this morning. Specifically, evaluating Nature Medicine and the value of publication in that magazine. Who wrought the fixation on that publication? Not anyone friendly toward scientific progress. The HIV rehash we've been waiting for includes (I'll list only two for fear of boredom): "Structural definition of a conserved neutralization epitope on HIV-1 gp120", and how about "Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells". It's a different world, and not a bavi new world. A different attack strategy. Important, but not PPHM or Duke. A different league. PPHM and Duke could put these guys out of business. Probably some of the posters here. Hey a love the board here but the scene is still cluttered by big pharma goons. Let's move the ball forward. PPHM has incredible momentum now. The "New Scientist" article says it all. Look at who is financing Nature. It isn't the guy on the street payin' a dime for that news. It is big Pharma tootin' it ancient horns. Let's stay focused and get the message through.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News